{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Brookhaven",
      "state": "NY",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "83137",
      "recalling_firm": "Amneal Pharmaceuticals, Inc.",
      "address_1": "50 Horseblock Rd",
      "address_2": "N/A",
      "postal_code": "11719-9509",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide within the United States",
      "recall_number": "D-1438-2019",
      "product_description": "Esterified Estrogens & Methyltestosterone Tablets, USP  0.625 mg/1.25 mg, 100-count bottles, Rx Only, Manufactured by: Ammeal Pharmaceuticals of NY Hauppauge, NY 11788 Distributed by: Seton Pharmaceuticals Manasquan, NJ 08736, NDC 13925-171-01",
      "product_quantity": "19104 units",
      "reason_for_recall": "Subpotent Drug: Out of specification assay result in Esterified Estrogen and Methyltestosterone tablets.",
      "recall_initiation_date": "20170925",
      "center_classification_date": "20190701",
      "termination_date": "20190808",
      "report_date": "20190710",
      "code_info": "Lot #: HL05715, HL05815, Exp. 11/2017"
    }
  ]
}